PHM5 ADVATE IS COST-EFFECTIVE INVESTMENT IN HEMOPHILIA A TREATMENT WHEN PATHOGENS EMERGE—A SCENARIO-BASED ECONOMIC AND POSITIVE INVESTMENT INTERVAL (Pll) EVALUATION
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65032-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)65032-2/fulltext
Title :
PHM5 ADVATE IS COST-EFFECTIVE INVESTMENT IN HEMOPHILIA A TREATMENT WHEN PATHOGENS EMERGE—A SCENARIO-BASED ECONOMIC AND POSITIVE INVESTMENT INTERVAL (Pll) EVALUATION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65032-2&doi=10.1016/S1098-3015(10)65032-2
First page :
Section Title :
Open access? :
No
Section Order :
191